On July 20, New York’s Attorney General announced it had reached agreements with drug distributors McKesson, Cardinal Health, and Amerisource Bergen, in a case regarding their alleged role in the prescription opioid epidemic. The settlement agreement requires the companies to pay $1.1 billion over the next 17 years, and participate in a tracking system designed to control the number of opioids sold and shipped to U.S. pharmacies. The trial involving the three remaining defendants – opioid manufacturers Endo Health Solutions, Teva Pharmaceuticals USA, and Allergan Finance – is currently underway in state court in New York.